<html><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta http-equiv="Content-Style-Type" content="text/css" /><meta name="generator" content="Aspose.Words for .NET 13.4.0.0" /><title></title></head><body><div><p style="margin:0pt; text-align:right"><span style="font-family:Calibri; font-size:11pt">&#xa0;</span></p><p style="margin:0pt"><span style="font-family:Calibri; font-size:11pt">&#xa0;</span></p><p style="margin:5pt 0pt; text-align:center"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">Written evi</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">dence submitted on behalf of</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">Roche Diagnostics </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">UK </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">(LTC 73)</span></p><p style="margin:5pt 0pt 11.25pt; text-align:justify"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">Summary</span></p><ol type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; list-style-position:inside; margin:5pt 0pt 0pt; text-align:justify; text-indent:0pt"><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">Long-</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">term conditions, defined by the Department of Health as ‘conditions that cannot, at present, be cured but can be controlled by medication and other therapies’ </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">have a major impact on quality of life, disability and are the main cause of premature death</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> in England</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">; they also account for a significant </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">proportion of NHS expenditure.</span></li></ol><p style="margin:5pt 0pt 11.25pt 36pt; text-align:justify"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">&#xa0;</span></p><ol start="2" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; list-style-position:inside; margin:0pt; text-align:justify; text-indent:0pt"><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">T</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">he NHS has been largely successful at tackling Beveridge’s ‘g</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">iant’ of disease</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">,</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> therefore long-</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">term conditions will assume greater abs</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">olute and relative importance. </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">The challenge now is to support the nearly 1 in 3 people – over 20 million in England </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">–</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> who have at least one long-term condition: whether diabetes, coronary heart disease, etc. or as a survivor of cancer treatment.</span></li></ol><p style="margin:0pt 0pt 0pt 36pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">&#xa0;</span></p><ol start="3" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; list-style-position:inside; margin:0pt; text-align:justify; text-indent:0pt"><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">This challenge highlights two major concerns: whether the NHS in its current form (largely funded through general taxation with access free at the point of use) is affordable – people wi</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">th long-</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">term conditions account for 70 per cent of expenditure on health and care; and whether the current model with its emphasis on the investment in the provision of treatment by medical practitioners in acute care settings is appropriate for people wit</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">h long-term conditions.</span></li></ol><p style="margin:0pt 0pt 0pt 36pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">&#xa0;</span></p><ol start="4" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; list-style-position:inside; margin:0pt 0pt 11.25pt; text-align:justify; text-indent:0pt"><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">This submission, whilst recognising the need for a paradigm shift, such as </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">those</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> advocated by Wagner</span><a name="_ftnref1"></a><a href="#_ftn1">[1]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> (1998) and Kane et al</span><a name="_ftnref2"></a><a href="#_ftn2">[2]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> (2005) to a Chronic Care Model; and emphasis on evidence-based preven</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">tative interventions such as nutrition and </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">physical activity, advocates that the use of technology facilitating self</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">-management by people with long-</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">term conditions in an integrated health and social care system is an </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">integral</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> part of the solution.</span></li></ol><p style="margin:5pt 0pt 11.25pt; text-align:justify"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">Introduction</span></p><ol start="5" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; list-style-position:inside; margin:5pt 0pt 0pt; text-align:justify; text-indent:0pt"><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">P</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">eop</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">le with long-</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">term conditions are </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">often </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">the most important pr</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">imary care provider,</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> where long-</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">term conditions are a major bu</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">rden of disease (Sobel</span><a name="_ftnref3"></a><a href="#_ftn3">[3]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">, 1995). </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">Given that most care </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">has </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">always been self-care, any reduction in self-management will result in a potentially insupportable burden on health and care services.</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">The Expert Patient Programme in England demonstrated the benefits of self-management support (Kennedy et al 2007)</span><a name="_ftnref4"></a><a href="#_ftn4">[4]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">.</span></li></ol><p style="margin:0pt 0pt 0pt 36pt; text-align:justify"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">&#xa0;</span></p><ol start="6" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; list-style-position:inside; margin:0pt; text-align:justify; text-indent:0pt"><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">Over the past ten or so years, government policy has sought to shift emphasis towards a primary care led NHS as part of a move towards an integrated health and care system</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">,</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> with emphasis being placed on fostering a more person-centred approach to care, taking a holistic view of an individual’s needs to help them live as independently as possib</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">le.</span></li></ol><p style="margin:0pt; text-align:justify"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">&#xa0;</span></p><ol start="7" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; list-style-position:inside; margin:0pt; text-align:justify; text-indent:0pt"><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">T</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">he Quality and Outcomes Framework (QOF) introduced in 2004 provides a financial incentive for GPs (10</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">–</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">15 per cent of the remuneration) based on achieving a range of nationally set quality-based targets focused on ill-health prevention through the effective management of people with, or at risk of, developing a range of long-term conditions. QOF incentive payments have already been shown to have a positive impact on the nature and quality </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">of care (Campbell et al 2007)</span><a name="_ftnref5"></a><a href="#_ftn5">[5]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">.</span></li></ol><p style="margin:0pt 0pt 0pt 36pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">&#xa0;</span></p><ol start="8" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; list-style-position:inside; margin:0pt; text-align:justify; text-indent:0pt"><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">Consideration should be given to extending or looking at similar incentives to achieve the ‘paradigm shift’, recognising that this will require disinves</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">tment elsewhere in the system. </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">At a policy level</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">,</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> we have seen the integrated care pilots established as part of the NHS Next Stage Review, and </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">more recently, the Health and Social Care Act 2012 places a duty on providers to work more closely together to address these issues.</span></li></ol><p style="margin:0pt 0pt 0pt 36pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">&#xa0;</span></p><ol start="9" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; list-style-position:inside; margin:0pt; text-align:justify; text-indent:0pt"><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">Ham identifies ten characteristics of a ‘high-performing chronic care system (Ham, 2010)</span><a name="_ftnref6"></a><a href="#_ftn6">[6]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">.</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">These include: ‘priority is given to patients to self-manage their conditions with support from carers and families’, ‘priority is given to primary health care’ and, ‘the need to exploit the potential benefits of information technology in improving chronic care’</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">.</span></li></ol><p style="margin:0pt 0pt 0pt 36pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">&#xa0;</span></p><ol start="10" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; list-style-position:inside; margin:0pt 0pt 11.25pt; text-align:justify; text-indent:0pt"><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">Below are </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">three examples of</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> patient groups</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> who </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">take</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> a leading role in the day-to-day management of their condition</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">;</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> where </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">self-monitoring is helping them stay healthy</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">, </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">reducing complications and generating savings for the NHS.</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span></li></ol><p style="margin:5pt 0pt 11.25pt; text-align:justify"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">Warfarin monitoring</span></p><ol start="11" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; list-style-position:inside; margin:5pt 0pt 0pt; text-align:justify; text-indent:0pt"><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">Warfarin is the main oral anticoagulant used in the UK</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">.</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> Anticoagulant medicines are most commonly prescribed for people who have had a condition caused by a blood clot (thrombosis) or are at risk of developing one. These conditions include:</span></li></ol><p style="margin:0pt; text-align:justify"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">&#xa0;</span></p><ul type="disc" style="margin:0pt; padding-left:0pt"><ul type="disc" style="margin:0pt; padding-left:0pt"><li style="font-family:Symbol; font-size:11pt; margin:0pt 0pt 0pt 64.06pt; padding-left:7.94pt; text-align:justify; text-indent:0pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">deep vein thrombosis (DVT)</span></li><li style="font-family:Symbol; font-size:11pt; margin:0pt 0pt 0pt 64.06pt; padding-left:7.94pt; text-align:justify; text-indent:0pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">pulmonary embolism</span></li><li style="font-family:Symbol; font-size:11pt; margin:0pt 0pt 0pt 64.06pt; padding-left:7.94pt; text-align:justify; text-indent:0pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">atrial</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> fibrillation (AF) </span></li></ul></ul><p style="margin:0pt 0pt 0pt 72pt; text-align:justify"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">&#xa0;</span></p><ol start="12" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; list-style-position:inside; margin:0pt; text-align:justify; text-indent:0pt"><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">Warfarin may also be prescribed for people with a replacement or mechanical heart valve.</span></li></ol><p style="margin:0pt 0pt 0pt 36pt; text-align:justify"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">&#xa0;</span></p><ol start="13" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; list-style-position:inside; margin:0pt; text-align:justify; text-indent:0pt"><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">There are more than 1.2 million people in the UK on warfarin (Gardiner</span><a name="_ftnref7"></a><a href="#_ftn7">[7]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> et al, 2004, ONS</span><a name="_ftnref8"></a><a href="#_ftn8">[8]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> 2008).</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">Connock</span><a name="_ftnref9"></a><a href="#_ftn9">[9]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> et al (2007) estimated that numbers continue to increase by about 10% each year, primarily driven by its use for patients with atrial fibrillation. The future impact of this expansion is indicated by estimates that currently more than half of those with atrial fibrillation may remain unidentified and less than half of those identified may be receiving treatment. These estimates considered together with an ageing population mean that future service load could increase substantially.</span></li></ol><p style="margin:0pt 0pt 0pt 36pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">&#xa0;</span></p><ol start="14" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; list-style-position:inside; margin:0pt; text-align:justify; text-indent:0pt"><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">However, it is estimated that fewer than two per cent of them benefit from</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> self-monitoring (Roche data). </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">Self-monitoring has been shown to reduce the risk of stroke by over 50 per cent and reduce mortality rates by nearly two fifths (Henegan C</span><a name="_ftnref10"></a><a href="#_ftn10">[10]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> et al, 2006). Better access to self-monitoring of international normalized ratio (INR) levels, which measures how long it takes blood to form a clot, could also reduce the number of complications. Current estimates show that oral anticoagulation therapy (OAT) management of stable patients costs the NHS around £409 million (Fitzmaurice DA</span><a name="_ftnref11"></a><a href="#_ftn11">[11]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> et al, 2005, NICE</span><a name="_ftnref12"></a><a href="#_ftn12">[12]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> 2006). Studies also show that if only one in four patients took up self-monitoring (Connock et al, 2007) this would save the NHS approximately £62 million per year (Roche data)</span><a name="_ftnref13"></a><a href="#_ftn13">[13]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">.</span></li></ol><p style="margin:0pt 0pt 0pt 36pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">&#xa0;</span></p><ol start="15" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; list-style-position:inside; margin:0pt 0pt 11.25pt; text-align:justify; text-indent:0pt"><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">The CoaguChek XS is a Point of Care (POC) device used by competent patients to monitor and manage their INR levels, thereby reducing the burden on NHS resources. The device uses blood sample from a finger prick applied to a testing strip. The result is displayed within a minute of applying the blood sample, and if needed, adjustments to warfarin dosage made. This gives the patient more freedom to travel and avoids</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">disruption to work and home life that potentially frequent visits to </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">anticoagulation clinics can cause.</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">Patient self-management can – and where appropriate should – empower the patient to determine the dose adjustment with the support of resources, such as dosing charts and access to advice if required.</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span></li></ol><p style="margin:5pt 0pt 11.25pt; text-align:justify"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">Deep Vein Thrombosis</span></p><ol start="16" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; list-style-position:inside; margin:5pt 0pt 0pt; text-align:justify; text-indent:0pt"><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">Deep vein thrombosis (DVT) is a cause of 25,000 deaths in the UK each year and can lead to the development of post thrombotic syndrome (PTS) with chronic swelling and ulceration of the legs (Health Committee 2004/5)</span><a name="_ftnref14"></a><a href="#_ftn14">[14]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">.</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">DVT can be clinically very difficult to diagnose but early recognition and appropriate treatment can improve clinical outcomes.</span></li></ol><p style="margin:0pt 0pt 0pt 36pt; text-align:justify"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">&#xa0;</span></p><ol start="17" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; list-style-position:inside; margin:0pt; text-align:justify; text-indent:0pt"><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">In response to the National Guidance on Care Close to Home (NHS Local 2010)</span><a name="_ftnref15"></a><a href="#_ftn15">[15]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> in May 2010 a DVT service was initiated at Solihull Healthcare and Walk-in Centre which enables uncomplicated DVT identification and management using D-dimer testing, hastening patient care and avoiding referrals to hospital.</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">In the first 11 months of the service, 355 patients were tested for DVT, saving in excess of £220,000 from reduced hospital admissions, with feedback showing an improved patient experience.</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">The </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">Cobas</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">® H232 D-</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">Dimer</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> diagnostic test is a point of care (POC) blood test that can be carried out in primary care</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">and can be used to rule out VTE. The sample required is from a finger prick and a result is given within 8 minutes</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">.</span></li></ol><p style="margin:0pt 0pt 0pt 36pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">&#xa0;</span></p><ol start="18" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; list-style-position:inside; margin:0pt 0pt 11.25pt; text-align:justify; text-indent:0pt"><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">Similarly, in 2009 South West Essex community services, now part of North East London Foundation Trust, established a DVT service based at Brentwood Community Hospital aimed at improving DVT diagnostic services for nine GP practices in the Brentwood area, serving a population of 74,000.</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">The DVT service sees on average 250 patients per year. With each acute DVT presentation costing approximately £500 per patient if referred to secondary care.</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">However, all patients can now be assessed and managed in primary care with an approximate annual saving of £60,000.</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">Savings are also made in time, as well as in costs. Following a suspected DVT referral to the Community Hospital it takes approximately 30 - 60 minutes for a patient to be seen and assessed, including carrying out the D-dimer test - patients report that being able to have their condition assessed more rapidly and in a primary care setting is much less stressful for them.</span></li></ol><p style="margin:5pt 0pt 11.25pt; text-align:justify"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">Diabetes </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">C</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">are </span></p><ol start="19" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; list-style-position:inside; margin:5pt 0pt 0pt; text-align:justify; text-indent:0pt"><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">D</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">iabetes is a long-term chronic</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> condition caused by too much glucose (sugar) in the blood.</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">There are two types of Diabetes: Type 1 occurs when your immune system destroys the beta cells in the pancreas that create insulin. As a result, the body makes very little or no insulin of its own. People with Type 1 diabetes must take insulin daily. In Type 2, not enough insulin is produced or the insulin that is made by the body doesn't work properly. Type 2 diabetes can affect people at any age.</span></li></ol><p style="margin:0pt 0pt 0pt 36pt; text-align:justify"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">&#xa0;</span></p><ol start="20" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; list-style-position:inside; margin:0pt; text-align:justify; text-indent:0pt"><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">According to Diabetes UK, between 2006 and 2011, the number of people diagnosed with diabetes in England increased by 25 per cent, from 1.9 million to 2.5 million. There has also been a huge growth in complication rates during this time. Diabetes is now the biggest single cause of amputation, stroke, blindness, and end-stage kidney failure. The reality of any of those devastating outcomes for patients demonstrates the NHS is not able to plan for or manage the realities of long-term diabetes outcomes, including the multiple conditions a person with diabetes is likely to develop in the later stages of having the condition.</span></li></ol><p style="margin:0pt 0pt 0pt 36pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">&#xa0;</span></p><ol start="21" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; list-style-position:inside; margin:0pt; text-align:justify; text-indent:0pt"><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">While there have been some demonstrable improvements in diabetes care since the National Service Framework for Diabetes was first introduced in 2001, annual National Diabetes Audits indicate there remains is a great deal of work to do, including tackling poor provision of structured education and increased delivery of personalised diabetes care</span><a name="_ftnref16"></a><a href="#_ftn16">[16]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">.</span></li></ol><p style="margin:0pt 0pt 0pt 36pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">&#xa0;</span></p><ol start="22" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; list-style-position:inside; margin:0pt 0pt 11.25pt; text-align:justify; text-indent:0pt"><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">Considering current diabetes spend accounts for around 10 per cent of the NHS budget, we need to ensure that everything is being done to encourage patients to maintain </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">good</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> diabetes control</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">.</span></li></ol><p style="margin:0pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">Self-</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">monitoring of blood glucose (SMBG) </span></p><ol start="23" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; list-style-position:inside; margin:5pt 0pt 0pt; text-align:justify; text-indent:0pt"><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">Monitoring </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">blood glucose is </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">a </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">very impor</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">tant part of managing diabetes. </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">Regularly testing blood glucose helps measure the effectiveness of </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">a patient’s </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">dietary planning, exercise and medication</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">, with good control helping reduce longer-term complications.</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> In order to </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">self-test</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> blood glucose</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">, a patient needs a blood glucose meter, a test strip and a finger pricker. </span></li></ol><p style="margin:0pt; text-align:justify"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">&#xa0;</span></p><ol start="24" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; list-style-position:inside; margin:0pt; text-align:justify; text-indent:0pt"><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">In England, the blood glucose meter and</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> finger pricke</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">r is provided free </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">through </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">the NHS via </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">a</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> healthcare professional. Test strips are then provided on prescription, with the </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">number of tests allocated</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> based on the </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">frequency of testing </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">require</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">d</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">e.g.</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">depending on the type of diabetes you have, your level of physical </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">activity</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> and how frequently you drive.</span></li></ol><p style="margin:0pt 0pt 0pt 36pt; text-align:justify"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">&#xa0;</span></p><ol start="25" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; list-style-position:inside; margin:0pt; text-align:justify; text-indent:0pt"><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">Unfortunately</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">, </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">short-term financial savings</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">by </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">CCGs are</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">,</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> in an increasing number of incidences</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">,</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> threatening self-management</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">,</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> for example</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">,</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> restrictions around access to blood glucose test strips or inconsistent formulary processes/decisions surrounding the type of blood glucose meter made available to patients.</span></li></ol><p style="margin:0pt 0pt 0pt 36pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">&#xa0;</span></p><ol start="26" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; list-style-position:inside; margin:0pt; text-align:justify; text-indent:0pt"><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">There are 250,000 people with Type 1 diabetes in England. Their lives depend on insulin injection or pump treatment, which requires them to regularly carry out self-blood glucose measurement</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">s</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> (SBGM)</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">, normally several tests a day </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">e.g.</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> upon waking, before/after eating and before bed.</span></li></ol><p style="margin:0pt 0pt 0pt 36pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">&#xa0;</span></p><ol start="27" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; list-style-position:inside; margin:0pt; text-align:justify; text-indent:0pt"><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">However, people with Type 1 diabetes are increasingly being r</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">estricted access to </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">test strips.</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">In a letter circulated to General Practitioners, Hospital Doctors, Community Pharmacists and PCT Chief Executives in February 2013, </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">the National Clinical D</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">irector for Diabetes</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">reaffirmed the importance of</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">testing, </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">stating</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">it is ‘essential that people with Type 1 diabetes are prescribed sufficient SBGM testing strips for their clinical needs (as outlined in NICE guidance CG15, TA 60). This enables people with diabetes to self-manage, recognising the symptoms of </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">Diabetic ketoacidosis</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">, encouraging them to</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">take </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">ea</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">rly action and</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> seek help, especially if it involves driving.</span></li></ol><p style="margin:0pt 0pt 0pt 36pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">&#xa0;</span></p><ol start="28" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; list-style-position:inside; margin:0pt 0pt 11.25pt; text-align:justify; text-indent:0pt"><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">The letter also clarified that </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">“While testing strips dispensed in primary care may appear to have a premium cost, the wider costs to the patient’s quality of life, their safety and ability to work and to the NHS of complications of uncontrolled diabetes far outweigh these costs</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">, including the cost of repeated unplanned A&amp;E admissions</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">. Further costs for the strips in most cases also include provision of educational material, meters, and helplines for patients by the manufacturer</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">.”</span><a name="_ftnref17"></a><a href="#_ftn17">[17]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span></li></ol><p style="margin:5pt 0pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">Access to innovative </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">blood glucose meters </span></p><ol start="29" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; list-style-position:inside; margin:5pt 0pt 0pt; text-align:justify; text-indent:0pt"><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">R</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">ecent adva</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">nces in technology have made </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">insulin </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">bolus advisors </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">available to patients on multiple daily injections (MDI). Bolus advisors support patients on MDI, using a long acting basal insulin </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">analogue</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> to achieve optimal diabetes control. </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">Individually programmed, patients can just test their</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> blood glucose levels w</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">ith the system, enter the carbs</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> they are</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> about to eat and receive bolus advise.</span></li></ol><p style="margin:0pt 0pt 0pt 36pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">&#xa0;</span></p><ol start="30" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; list-style-position:inside; margin:0pt 0pt 11.25pt; text-align:justify; text-indent:0pt"><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">An online user survey </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">of patients </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">showed</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> that the majority of respondents felt using the bolus advisor improved confidence in the accuracy of the mealtime bolus insulin dose and reduced their fear of hypos. Patients found the system easy and motivating to use with 72% respondents reporting overall wellbeing/life with diabetes had improved or significantly improved since using their bolus advisor, with greater confidence and control in their diabetes management.</span><a name="_ftnref18"></a><a href="#_ftn18">[18]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span></li></ol><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt"><br style="page-break-before:always; clear:both" /></p><p style="margin:0pt 0pt 10pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">A</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">ccess to </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">i</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">nsulin pump therapy</span></p><ol start="31" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; list-style-position:inside; margin:5pt 0pt 0pt; text-align:justify; text-indent:0pt"><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">The role of insulin pumps for Type 1 diabetics is recognised worldwide and has been endorsed in the UK by NICE. </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">T</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">he use of insulin pumps in the UK </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">remains </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">low compar</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">ed to other developed nations, h</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">owever, in the last 4 to 5 years we have seen a significant rise in the numbers of pumps being used.</span></li></ol><p style="margin:0pt 0pt 0pt 36pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">&#xa0;</span></p><ol start="32" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; list-style-position:inside; margin:0pt 0pt 11.25pt; text-align:justify; text-indent:0pt"><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">Working in partnership to improve pump uptake, Roche</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> has made a significant contribution to this growth through a complete service offering for our NHS partners from patient/healthcare professional education through to a 24 hour careline for our patients. Our educational pump courses have helped to train over 250 DSNs on the practicalities and benefits of pump therapy helping to expand the number of centres offering pump therapy.</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">&#xa0;</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">We believe our work has helped many 100s of patients gain access to pump therapy who wouldn’t otherwise have done so.</span></li></ol><p style="margin:0pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">Commissioning support</span></p><ol start="33" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; list-style-position:inside; margin:5pt 0pt 0pt; text-align:justify; text-indent:0pt"><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">Practical assistance </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">for </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">commissioners to support the design of </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">local diabetes </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">services</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> have in past been provided by NHS Diabetes. While that best practice remains relevant,</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">Roche Diabetes Care is concerned the closure of NHS Diabetes </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">and poor awareness of their previous work </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">will leave CCGs and commissioners without the necessary information required to understand and appropriately design and commission </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">high-quality diabetes </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">services. </span></li></ol><p style="margin:0pt 0pt 0pt 36pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">&#xa0;</span></p><ol start="34" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; list-style-position:inside; margin:0pt 0pt 11.25pt; text-align:justify; text-indent:0pt"><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">While the NHS Diabetes website will be kept open for several months, we would like to see the expert knowledge and best practice transferred and made available on the new NHS Improvement website, with commissioners being encouraged to engage with existing best practice. </span></li></ol><p style="margin:0pt 0pt 10pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">Conclusion</span></p><ol start="35" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; list-style-position:inside; margin:5pt 0pt 0pt; text-align:justify; text-indent:0pt"><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">Long-</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">term conditions account for: 50</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">per cent of GP appointments, 70</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">per cent of bed days and 70</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">per cent of health and care budgets.</span></li></ol><p style="margin:0pt 0pt 0pt 36pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">&#xa0;</span></p><ol start="36" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; list-style-position:inside; margin:0pt; text-align:justify; text-indent:0pt"><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">The technology for self-monitoring and management is available.</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">Remote and other forms of diagnostic monitoring are being further developed to support self and directed management approaches.</span></li></ol><p style="margin:0pt; text-align:justify"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">&#xa0;</span></p><ol start="37" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; list-style-position:inside; margin:0pt 0pt 11.25pt; text-align:justify; text-indent:0pt"><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">However, the uptake of innovative </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">technology by the NHS is slow. </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">Whilst recognising that to derive the maximum benefits from the use of such technology, services must be redesigned – and not just to realise the potential savings or to release resources for reinvestment – but to achieve the holistic benefits for the individual, as well as society as a whole, the examples above show what can be achieved within the current NHS and social care model.</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">The potential for the use of such technology within a new model of care, such as the Chronic Care Model, is arguably greater still.</span></li></ol><p style="margin:0pt 0pt 10pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">About Roche Diagnostics UK </span></p><ol start="38" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; list-style-position:inside; margin:5pt 0pt 0pt; text-align:justify; text-indent:0pt"><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">Roche Diagnostics is the world’s largest in vitro diagnostics company, supplying high quality products and services which are used to diagnose and monitor medical conditions and facilitate medical research. From small devices used directly by patients or healthcare professionals, to large diagnostic instruments found in hospital laboratories, Roche has a track record of developing new and innovative devices.</span></li></ol><p style="margin:0pt 0pt 0pt 36pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">&#xa0;</span></p><ol start="39" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; list-style-position:inside; margin:0pt 0pt 11.25pt; text-align:justify; text-indent:0pt"><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">Roche has pioneered the development of hand held systems, empowering patients with diabetes and those receiving anticoagulation therapy, to monitor their own long-term conditions easily and accurately.</span></li></ol><p style="margin:0pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">Roche Diabetes Care’s </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">Accu-Chek</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">® brand is the world leader in diabetes care, with a diverse portfolio of products designed to help people with diabetes live healthy, productive lives and to make managing diabetes easier.</span></p><p style="margin:0pt 0pt 0pt 36pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt 0pt 10pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-style:italic">May 2013</span></p></div><hr style="width:33%; height:1px; text-align:left" /><p style="margin:0pt"><a name="_ftn1"></a><a href="#_ftnref1">[1]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt">Wagner E (1998) ‘Chronic disease management: what will it take to improve care for chronic illness?’ Effective Clinical Practice, 1: 2-4</span></p><p style="margin:0pt"><a name="_ftn2"></a><a href="#_ftnref2">[2]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt">Kane R, R Priester and A Totten (2005) Meeting the Challenge of Chronic Illness, Baltimore: The John Hopkins University Press</span></p><p style="margin:0pt"><a name="_ftn3"></a><a href="#_ftnref3">[3]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt">Sobel D (1995) ‘Rethinking medicine: improving health outcomes with cost-effective psychosocial interventions’ Psychosomatic medicine, 57: 234-244</span></p><p style="margin:0pt"><a name="_ftn4"></a><a href="#_ftnref4">[4]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt">Kennedy A, et al (2007) ‘The effectiveness and cost effectiveness of a nationally led self-care support programme for patients with long term conditions: a pragmatic randomised control trial’ Journal of Epidemiology and Community Health 61(3): 254-261</span></p><p style="margin:0pt"><a name="_ftn5"></a><a href="#_ftnref5">[5]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt">Campbell S, D Reeves, E Kontopantelis, E Middleton, B </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt">Sibblad</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt">and M Roland (2007) ‘Quality of primary care in England with the introduction of pay for performance’ New England Journal of Medicine 357: 181-190</span></p><p style="margin:0pt"><a name="_ftn6"></a><a href="#_ftnref6">[6]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt">Ham C (2010) ‘The ten characteristics of the high-performing chronic care system’ Health Economics, Policy and Law 5: 71-90</span></p><p style="margin:0pt"><a name="_ftn7"></a><a href="#_ftnref7">[7]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt"> Gardiner et.al. Patient self-testing is a reliable and acceptable alternative to laboratory monitoring. Br J Haem 2004; 128:242-47</span></p><p style="margin:0pt"><a name="_ftn8"></a><a href="#_ftnref8">[8]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt"> Office for National Statistics 2008. Accessed 16 June 2011</span></p><p style="margin:0pt"><a name="_ftn9"></a><a href="#_ftnref9">[9]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt"> Connock M, Stevens C, Fry-Smith A, Jowett S, Fitzmaurice D, Moore D, et al. Clinical effectiveness and cost-effectiveness of different models of managing long-term oral anticoagulation therapy: a systematic review and economic modelling [online]. Health Technol.Assess. 2007 ix-66; Oct;11(38):iii-iv, ix-66</span></p><p style="margin:0pt"><a name="_ftn10"></a><a href="#_ftnref10">[10]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt"> Heneghan C et al. Self-monitoring of oral anticoagulation: a systematic review and meta-analysis. Lancet 2006;367(9508):404-11.</span></p><p style="margin:0pt"><a name="_ftn11"></a><a href="#_ftnref11">[11]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt"> Fitzmaurice DA et al. Self-Management of Oral Anticoagulation Therapy (SMART Trial). BMJ 2005; 331: 1057</span></p><p style="margin:0pt"><a name="_ftn12"></a><a href="#_ftnref12">[12]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt"> Atrial Fibrillation. Clinical Guideline No. 36. Costing Report NICE 2006</span></p><p style="margin:0pt"><a name="_ftn13"></a><a href="#_ftnref13">[13]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt"> This figure takes into account all secondary care costs, primary care costs and costs of the CoaguChek XS device and test strips</span></p><p style="margin:0pt"><a name="_ftn14"></a><a href="#_ftnref14">[14]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt"> S</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt">econd report of session 2004-5 of The House of Commons Health Committee 'The Prevention of Venous Thromboembolism in Hospitalised Patients’</span></p><p style="margin:0pt"><a name="_ftn15"></a><a href="#_ftnref15">[15]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt"> NHS Local 2010 ‘Giving GPs power to decide on healthcare in Solihull – http://nhslocal.uk/story/features/giving-gps-power-decide-healthcare-solihull (accessed 19 March 2012)</span></p><p style="margin:0pt"><a name="_ftn16"></a><a href="#_ftnref16">[16]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt"> http://www.hscic.gov.uk/nda (accessed 7 May 2013)</span></p><p style="margin:0pt"><a name="_ftn17"></a><a href="#_ftnref17">[17]</a><span style="font-family:Calibri; font-size:10pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt">https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/156336/Safe-care-of-people-with-type-1-diabetes.pdf.pdf (accessed 7 May 2013)</span></p><p style="margin:0pt"><a name="_ftn18"></a><a href="#_ftnref18">[18]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt"> Barnard K, Parkin C et al. Use of an automated bolus calculator reduces fear of hypoglycaemia and improves confidence in dosage accuracy in T1DM patients treated with multiple daily insulin injections., J Diabetes Sci Technol 2012;6:145–149</span></p></body></html>